Ajovy 3 posts

• Teva and status on CGRP migraine drugs
  7 August 2019  ·  pharma TEVA CGRP
  Teva Pharmaceuticals issued a press release on their Q2 earnings on August 7th.
• Teva still suffers from negative revenue growth and return to growth is still distant
  2 May 2019  ·  Ajovy Austedo Copaxone
• Teva and the approval of the migraine drug Ajovy®
  23 September 2018  ·  Eli Lilly Aimovig Ajovy